Altogether, these data demonstrate a signaling pathway to mediate ERK1/2 activation by OR51E2 in which Gβγ translocation to the GA induces the activation of PI3Kγ and ARF1, and the GA provides a spatial platform in prostate cancer cells. Here, OR51E2 is linked to prostate carcinoma.